Literature DB >> 29160727

A Review of Perioperative Complications of Outpatient Total Ankle Arthroplasty.

Todd R Borenstein1, Kapil Anand2, Quanlin Li3, Timothy P Charlton1, David B Thordarson1.   

Abstract

BACKGROUND: Total ankle arthroplasty (TAA) is commonly pursued for patients with painful arthritis. Outpatient TAA are increasingly common and have been shown to decrease costs compared to inpatient surgery. However, there are very few studies examining the safety of outpatient TAA. In this study, we retrospectively reviewed 65 consecutive patients who received outpatient TAA to identify complication rates.
METHODS: The medical records of 65 consecutive outpatient TAA from October 2012 to May 2016 with a minimum 6-month follow-up were reviewed. All patients received popliteal and saphenous blocks prior to surgery and were managed with oral pain medication postoperatively. All received a STAR total ankle. Demographics, comorbidities, American Society of Anesthesiologists (ASA) class, and perioperative complications including wound breakdown, infection, revision, and nonrevision surgeries were observed. Mean follow-up was 16.6 ± 9.1 months (range, 6-42 months).
RESULTS: There were no readmissions for pain control and 1 patient had a wound infection. The overall complication rate was 15.4%. One ankle (1.5%) had a wound breakdown requiring debridement and flap coverage. This patient thrombosed a popliteal artery stent 1 month postop. The 1 ankle (1.5%) with a wound infection occurred in a patient with diabetes, obesity, hypertension, and rheumatoid arthritis.
CONCLUSION: This study demonstrates the safety of outpatient TAA. The combination of regional anesthesia and oral narcotics provided a satisfactory experience with no readmissions for pain control and 1 wound infection. The 1 wound breakdown complication (1.5%) was attributed to arterial occlusion and not outpatient management. LEVEL OF EVIDENCE: Level IV, retrospective case series.

Entities:  

Keywords:  ambulatory surgery; ankle arthritis; complications; outpatient surgery; total ankle arthroplasty; total ankle replacement

Mesh:

Year:  2017        PMID: 29160727     DOI: 10.1177/1071100717738748

Source DB:  PubMed          Journal:  Foot Ankle Int        ISSN: 1071-1007            Impact factor:   2.827


  7 in total

Review 1.  Management of Posttraumatic Ankle Arthritis: Literature Review.

Authors:  Samuel O Ewalefo; Malcolm Dombrowski; Takashi Hirase; Jorge L Rocha; Mitchell Weaver; Alex Kline; Dwayne Carney; MaCalus V Hogan
Journal:  Curr Rev Musculoskelet Med       Date:  2018-12

2.  Evaluating the Association between Anesthesia Type and Postoperative Complications for Patients Receiving Total Ankle Arthroplasty.

Authors:  Frank R Chen; Theodore Quan; Joseph E Manzi; Alex Gu; Chapman Wei; Sean Tabaie; Marc Chodos; Cary B Chapman; Kane O Pryor; Jiabin Liu
Journal:  Iowa Orthop J       Date:  2022-06

3.  Factors Predictive of Early Complications Following Total Ankle Arthroplasty.

Authors:  Christopher Del Balso; Mansur M Halai; Mark D MacLeod; David W Sanders; Abdel Rahman Lawendy
Journal:  Foot Ankle Orthop       Date:  2022-06-14

4.  The safety of foot and ankle procedures at an ambulatory surgery center.

Authors:  Peter Adamson; Wesley Peters; Cory Janney; Vinod Panchbhavi
Journal:  J Orthop       Date:  2020-03-28

5.  Safety and Effectiveness of Outpatient Total Ankle Arthroplasty.

Authors:  Shahin Kayum; Sahil Kooner; Ryan M Khan; Mansur Halai; Adam Awoke; Asa Kanani; Spencer Montgomery; Alexander Meldrum; Timothy R Daniels
Journal:  Foot Ankle Orthop       Date:  2021-11-23

6.  Outpatient total ankle replacement.

Authors:  Maxime Sadoun; Alexandre Hardy; Victoire Cladière; Leah Guichard; Thomas Bauer; Yves Stiglitz
Journal:  Int Orthop       Date:  2021-07-18       Impact factor: 3.075

7.  A propensity score-matched analysis comparing outpatient and short-stay hospitalization to standard inpatient hospitalization following total ankle arthroplasty.

Authors:  Mark A Plantz; Alain E Sherman; Anish R Kadakia
Journal:  J Orthop Surg Res       Date:  2020-07-31       Impact factor: 2.359

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.